ACTG Presents Important Findings from REPRIEVE at CROI 2025
To learn more, please visit www.reprievetrial.org.
ViiV announces new study data showing zero HIV cases with Apretude
GSK (GSK) announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer (PFE) and Shionogi (SGIOY) as ...
Tecovirimat is safe but ineffective as treatment for clade II mpox
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...
The Manila Times3h
ACTG Presents Data from Mpox Study STOMP at CROI
"The results from STOMP reinforce the value of randomized clinical trials during outbreaks of infectious diseases, like mpox, ...
Measles is unlike other viruses: What to know about long-term complications
Measles is unlike other childhood viruses. In severe cases, it can cause pneumonia. About 1 in 1,000 patients develops ...
Dermatology Advisor4h
Skin Cancer Risk Increases With Age Among People Living With HIV
Older adults with HIV are at significantly higher risk for cutaneous malignancies when compared with younger patients with HIV.
Infectious Disease Advisor5h
Neurocognitive Disorders in HIV Linked to Several Preexisting Comorbidities
Toxoplasmosis and MDD were among several preexisting comorbidities associated with the development of neurocognitive disorders in patients with HIV infection.
Infectious Disease Advisor5h
Severe Mpox, Long-Term Sequelae More Likely in Patients With Uncontrolled HIV
Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.
BioSpace6h
Gilead, GSK-ViiV Move Ahead With Long-Acting HIV Options Following Early-Stage Readouts
Gilead plans to go straight to Phase III studies for once-yearly lenacapavir, while GSK and Viiv will push forward with their ...
KFF Health News6h
Gilead’s HIV Drug Prevents Infection With One Shot A Year Instead Of Two
The company is planning a Phase 3 trial for the new formulation of lenacapavir, Stat reports. Other pharma and technology news is on microplastics and the spread of antibiotic-resistant superbugs; a ...